Advanced SearchSearch Tips
Brain somatic mutations in MTOR leading to focal cortical dysplasia
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 49, Issue 2,  2016, pp.71-72
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2016.49.2.010
 Title & Authors
Brain somatic mutations in MTOR leading to focal cortical dysplasia
Lim, Jae Seok; Lee, Jeong Ho;
  PDF(new window)
Focal cortical dysplasia type II (FCDII) is a focal malformation of the developing cerebral cortex and the major cause of intractable epilepsy. However, since the molecular genetic etiology of FCD has remained enigmatic, the effective therapeutic target for this condition has remained poorly understood. Our recent study on FCD utilizing various deep sequencing platforms identified somatic mutations in MTOR (existing as low as 1% allelic frequency) only in the affected brain tissues. We observed that these mutations induced hyperactivation of the mTOR kinase. In addition, focal cortical expression of mutant MTOR using in utero electroporation in mice, recapitulated the neuropathological features of FCDII, such as migration defect, cytomegalic neuron and spontaneous seizures. Furthermore, seizures and dysmorphic neurons were rescued by the administration of mTOR inhibitor, rapamycin. This study provides the first evidence that brain somatic activating mutations in MTOR cause FCD, and suggests the potential drug target for intractable epilepsy in FCD patients.
Focal cortical dysplasia;Mechanistic target of rapamycin;Mouse model;Somatic mutation;
 Cited by
Focal Cortical Dysplasia in Childhood Epilepsy, Seminars in Pediatric Neurology, 2016, 23, 2, 108  crossref(new windwow)